The largest database of trusted experimental protocols

3 protocols using ab150766

1

Protein Expression Analysis in HaCaT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After exposure or not to LIPUS, HaCaT cells were lysed in RIPA buffer (Beyotime, China) containing 1 mM phenylmethyl sulfonyl fluoride (PMSF; Beyotime). The whole lysates were centrifuged at 12,000 g for 10 min at 4°C, and the protein levels in the supernatants were quantified using the BCA™ Protein Assay Kit (Pierce, USA). Proteins were loaded onto SDS-PAGE gels and electroblotted onto polyvinylidene difluoride (PVDF) membranes. Then, PVDF membranes were blocked with 5% bovine serum albumin (BSA; Solarbio, China), and incubated overnight at 4°C with specific primary antibodies for cyclin D1 (ab134175), cyclin-dependent kinase (CDK) 6 (ab151247), CDK4 (ab137675), vascular endothelial growth factor (VEGF; ab150766), matrix metalloproteinase (MMP) 2 (ab97779), MMP-9 (ab137867), PI3K (ab180967), phospho (p)-PI3K (ab182651), β-actin (ab8227, all Abcam), AKT (#9272), p-AKT (#9271), JNK (#9252), and p-JNK (#9251, all Cell Signaling Technology, USA). After rinsing, PVDF membranes were incubated with HRP-conjugated secondary antibody (goat anti-rabbit, ab205718, Abcam) at room temperature. An enhanced chemiluminescence (ECL) kit (Thermo Scientific, USA) was used to detect the target proteins. Protein levels were quantified by ImageJ software (National Institutes of Health, USA).
+ Open protocol
+ Expand
2

Western Blot Analysis of Angiogenic Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total proteins were extracted from cultured cells by RIPA buffer (Beyotime Institute of Biotechnology, Nantong, China) with protease inhibitors (Protease inhibitor cocktail; Roche, Indianapolis, IN). Protein concentration was determined by using BCA protein assay (Thermo Fisher Scientific, U.S.A.). The protein samples (30 μg) were separated by SDS/PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, U.K.). The membranes were blocked with 5% nonfat milk/0.1% Tween 20 in phosphate-buffered saline (PBS-T) for 1 h at room temperature. Then the membranes were incubated with primary antibodies diluted appropriately in PBS-T at 4°C overnight. Antibodies specific to VE-cadherin (ab33168, 1:2000), VEGF (ab150766, 1:2000), β-catenin (ab32572, 1:2000), matrix metalloproteinase (MMP) 2 (MMP2) (ab97779, 1:2000), MMP9 (ab38898, 1:2000) and GAPDH (ab8245, 1:2000) were supplied by Abcam (Cambridge, U.K.). GAPDH was used as a loading control. After the incubation of primary antibodies, the membranes were washed with PBS-T for three times, 5 min each. Then the membranes were incubated with HRP–conjugated secondary antibodies (Cell Signaling Technology, Boston, U.S.A., 1:5000 in 5% nonfat milk/PBS-T) at room temperature for 1 h. After washing, the protein signals were visualized by ECL detection reagent (Amersham Biosciences, Castle Hill, Australia).
+ Open protocol
+ Expand
3

Analysis of AXL and Met Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against AXL (#8661), phospho-AXL (Tyr702) (#5724), phospho-MET (Tyr1234/1235) (#3077), AKT (#4685), phospho-AKT (ser473) (#4058), ERK (#4696), phospho-ERK (Thr202/Tyr204) (4376), GSK3β (9832), phospho-GSK3β (Ser9) (#5558), β-catenin (#8480), Snail (#3879), phospho-Src-Y416 (#6943) were purchased from Cell Signaling Technology. Antibody against Met (sc-161-R) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibody against AXL (#AF154) purchased from R&D systems (Minneapolis, MN) was used for IHC. Antibodies against VEGF (ab150766) and CD31 (ab28364) were purchased from Abcam (Cambridge, MA). Recombinant GAS6 (#885-GS-050) was purchased from R&D systems (Minneapolis, MN). Recombinant HGF (#GF116) was purchased from Millipore. Mitomycin C (#475820) was purchased from Calbiochem (Billerica, MA). Sunitinib (#s1042) was purchased from Selleckchem (Houston, TX). Cabozantinib was provided by Exelixis (South San Francisco, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!